Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TKNO · against 411 other Healthcare companies of similar size
Ranked #260 of 412 · scores higher than 11% of peers
Bars: peers in each 10-point band of the valuation score153 peers with a valuation score of 0–9, including TKNO · Click a bar to see the companies
Mainly because of its EBITDA yield and earnings yield, which are weaker than most Healthcare peers.
| Metric | TKNO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 398 reported | -4.2% | 0.0% | 38% | 30% | |
| EBITDA yieldHigher is better · 417 reported | -2.2% | 3.0% | 32% | 50% | |
| Free cash flow yieldHigher is better · 196 reported | -1.9% | -8.4% | 66% | 20% | |
| Book yieldHigher is better · 409 reported | 15.9% | 50.8% | 14% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 29.0B JPY (≈$197M) | 99 | 56 | |
| 260 | 354M USD | 8 | 13 | |
| 260 | 467M USD | 8 | 44 | |
| 260 | 549M USD | 8 | 30 | |
| 260 | 371M USD | 8 | ||
| 260 | 394M USD | 8 | 37 | |
| 260 | 513M USD | 8 | 31 | |
| 260 | 289M USD | 8 | ||
| 260 | 522M USD | 8 | 12 | |
| 260 | 227M USD | 8 | 24 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score